PAF makes it EZ(H2) for β-catenin transactivation

Area of Science:

• Molecular biology
• Cancer research
• Epigenetics

Background:

• Beta-catenin is a key protein in Wnt signaling, often dysregulated in colon cancer.
• PCNA-associated factor (PAF) is involved in transcriptional regulation.
• EZH2 is a histone methyltransferase implicated in cancer development.

Purpose of the Study:

• To investigate the role of PAF in the transcriptional activity of beta-catenin in colon cancer cells.
• To elucidate the mechanism by which PAF affects beta-catenin function.
• To explore the potential interplay between PAF-beta-catenin and PAF-PCNA interactions.

Main Methods:

• Co-immunoprecipitation assays to study protein-protein interactions.
• Reporter assays to measure transcriptional activity.
• Western blotting to detect protein levels.

Main Results:

• PAF binds to beta-catenin and enhances its transcriptional activity in colon cancer cells.
• PAF recruits EZH2 to the beta-catenin coactivator complex.
• The binding of PAF to beta-catenin is competitive with the binding of PAF to PCNA.

Conclusions:

• PAF acts as a novel coactivator for beta-catenin in colon cancer, promoting its transcriptional function.
• The recruitment of EZH2 by PAF-beta-catenin complex suggests a role in epigenetic regulation of target genes.
• The competitive interaction between PAF-beta-catenin and PAF-PCNA raises questions about beta-catenin's potential role in DNA replication and repair processes.